Clinical Trial Update: Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating gemcitabine and celecoxib in metastatic pancreatic cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Celecoxib (Celecoxib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED